Brief: Sprint Bioscience Resolves On Rights Issue Of Shares Of About SEK 31.7 Mln
March 14 (Reuters) - Sprint Bioscience AB SPRINT.ST: RESOLVES ON A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 31.7 MILLION SUBSCRIPTION PRICE AMOUNTS TO SEK 0.66 PER SHARE RIGHTS ISSUE IS COVERED TO APPROXIMATELY SEK 23.4 MILLION, CORRESPONDING TO APPROXIMATELY 73.9% OF THE RIGHTS ISSUE Source text: ID:nMFN5rycR Further company coverage: SPRINT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln